Mesh : Administration, Intravenous Administration, Oral Antifungal Agents / therapeutic use Coccidioides / isolation & purification Coccidioidomycosis / diagnostic imaging drug therapy Diagnosis, Differential Fluconazole / therapeutic use Humans Immunodiffusion Italy Lung Diseases, Fungal / diagnostic imaging drug therapy Male Middle Aged Tomography, X-Ray Computed Travel Treatment Outcome

来  源:   DOI:10.1007/s15010-014-0614-4

Abstract:
Coccidioidomycosis is a fungal infection caused by the Coccidioides species, which is endemic in the deserts of the southwestern region of the United States, northern Mexico, and in some areas of Central and South America. We describe a case of pulmonary coccidioidomycosis in a 49-year-old Italian man who came to our hospital with fever and joint and muscle pain 10 days after his return to Italy from Venezuela. Computer Tomography revealed multiple bilateral pulmonary nodules with mediastinal lymphadenopathy. Pulmonary coccidioidomycosis was diagnosed by a serological test, and fluconazole was immediately started. The patient improved within 2 weeks, with complete clinical recovery after 6 months of therapy. This case appears to be part of a large serologically unconfirmed outbreak. In order to provide early diagnosis and treatment, healthcare providers should be aware of coccidioidomycosis, even in travellers returning home from short trips to endemic areas.
摘要:
暂无翻译
公众号